1 / 6

Precision Medicine Market share to hit $88bn by 2023

Get more details @ http://bit.ly/2l3rNQ4 <br>Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics

jueekate
Télécharger la présentation

Precision Medicine Market share to hit $88bn by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Precision Medicine Market forecast to grow at 10.5% CAGR from 2016 to 2023: Fractovia.org Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights of Precision Medicine Market: • Precision medicine market size is expected to grow at a rate of 10.5% over 2016-2023; with growing occurrence of chronic diseases such as cancer needing more personalized treatments and practices. • Precision medicine will allow doctors to predict more accurately the medical treatment, prevention strategies and remedies. • This process allows the researcher to analyze the cause of a patient at the molecular level and then use targeted treatments. Expanding precision medicine trials in cancer genomics and technological advancements such as biomarker-based test kits and next generation sequencing will fast-track global precision medicine market growth. • Government support for these technologies will further boost precision medicine market scope over the forecast timeframe. For example, Precision Medicine Initiatives (PMI) commenced by U.S President Barack Obama in January 2015, will alter the concept of medicines, revolutionizing the medication and diagnosis perception.

  3. Continued… • Precision medicine finds wide applications in oncology, immunology, respiratory systems, and central nervous systems. • Precision medicine market revenue in Central Nervous System (CNS) worth USD 9 billion in 2015, is anticipated to grow significantly over the timeframe, owing to its wide application in brain circuitry. • Based on technology, precision medicine market is segmented into big data analytics, drug discovery, gene sequencing, companion diagnostics, and bioinformatics. Drug discovery based precision medicine market worth USD 9 billion in 2015, is anticipated to grow at a rate of 8.3% over the coming seven years. • North American precision medicine market is expected to grow significantly over the coming years due to favorable government regulations. U.S. is predicted to contribute significantly towards the regional share. • Key precision medicine industry participants include Laboratory Genomics of America Holdings, Intomics A/S, Silicon Biosystems, Eagle Genomics Limited, Roche, Covance, Pfizer, and Quest Diagnostics.

  4. Europe precision medicine market size, by application, 2013 - 2023 (USD Million)

  5. Browse Full Market Research Report Precision Medicine Market @ http://bit.ly/2jEWgH0 Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/250

  6. Stay In Touch Website: https://www.fractovia.org Social Media:

More Related